Virtual Diabetes Group Visits Across Health Systems

NCT06094491 · Status: ACTIVE_NOT_RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 720

Last updated 2025-10-08

No results posted yet for this study

Summary

The purpose of this project is to evaluate the effectiveness of a virtual diabetes group visits on patients with type 2 diabetes mellitus (T2DM).

Conditions

  • T2DM (Type 2 Diabetes Mellitus)
  • Hypertension
  • Heart Disease Chronic
  • Stroke
  • Hyperlipidemias
  • Peripheral Vascular Diseases
  • Obesity

Interventions

BEHAVIORAL

Virtual Group Visit

Group visits must have these core components: diabetes education, group social support and goal setting.

Sponsors & Collaborators

  • Wake Forest University Health Sciences

    collaborator OTHER
  • ACCESS Community Health Network

    collaborator OTHER
  • Midwest Clinicians' Network

    collaborator UNKNOWN
  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH
  • University of Chicago

    lead OTHER

Principal Investigators

  • Arshiya Baig, MD · University of Chicago

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-05-03
Primary Completion
2026-06-30
Completion
2026-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06094491 on ClinicalTrials.gov